Horizon Discovery Group plc Trading Update|
Monday, January 19, 2015
Revenues expected to be ahead of consensus by approximately 7% driven by an increased global demand for expanded product, service and IP offering.
CiToxLAB Announces the Appointment of Dr. Philippe Ancian as Senior Director
Wednesday, January 14, 2015
This appointment will allow to drive current and future developments at CiToxLAB’s European and North American sites in the area of preclinical and clinical biomarkers, which is currently experiencing strong growth.
XRpro Sciences Announces Completion of Equity Financing
Monday, January 12, 2015
The equity financing will contribute towards the growth of XRpro’s ion channel drug development technology.
Evotec and Padlock Therapeutics Extend Collaboration
Friday, January 09, 2015
Evotec and Padlock Therapeutics announce initial success and extension of long-term collaboration.
Bristol-Myers Squibb and Calibr Collaborate
Thursday, January 08, 2015
Collaboration and license agreement focused on new treatment approaches for fibrotic diseases.
MDxHealth CEO to Keynote at Biomarkers from Research to Clinic Conference
Monday, January 05, 2015
MDxHealth CEO Dr Jan Groen to deliver Keynote presentation at Biomarkers from Research to Clinic conference.
Oncodesign Enters into a Services Agreement with Eisai
Friday, December 26, 2014
The program aims to identify useful patient stratification biomarkers for Eisai’s Halaven® eribulin using patient-derived xenograft models.
A Standard for Neuroscience Data
Wednesday, December 24, 2014
Berkeley Lab researchers have developed a computational framework for standardizing neuroscience data worldwide.
Project to Focus on Link Between Immune System and Brain Disorders
Monday, December 22, 2014
Researchers to investigate whether mood disorders, such as depression, and neurodegenerative diseases, such as Alzheimer’s, could be treated by targeting the immune system.
|<< || 2 3 4 5 6 7 8 || >>|
|Showing Results 41 - 50 of 3579|